Fixed-Dose Tavapadon for Early Parkinson Disease: A Randomized Clinical Trial - Top-Institutions - MDSpire

Fixed-Dose Tavapadon for Early Parkinson Disease: A Randomized Clinical Trial

By
Rajesh Pahwa
Elena Moro
Alberto J. Espay
Andrew Evans
Marie Saint-Hilaire
Diego Torres-Russotto
Raymond Sanchez
Matthew Leoni
Sridhar Duvvuri
Cari Combs
Ih Chang
Stacey Tringali
Joey Boiser
Cindy Zadikoff
Angelo Antonini
May 1, 2026
0 min

Jama Neurology

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

#1

University of Kansas Medical Center

Kansas City, Kansas
Key Differentiators
- Neurology
- Movement Disorders
#2

University of Cincinnati College of Medicine

Cincinnati, Ohio
Key Differentiators
- Neurology
- Movement Disorders
#3

Beijing Hospital

Beijing, China
Key Differentiators
- Neurology
#4

Asian Myeloma Network

N/A, N/A
Key Differentiators
- Neurology
#5

Domain Specific Review Board

Singapore, Singapore
Key Differentiators
- Neurology

Original Source(s)

Jama Neurology

Fixed-Dose Tavapadon for Early Parkinson Disease: A Randomized Clinical Trial

by Rajesh Pahwa, Elena Moro, Alberto J. Espay, Andrew Evans, Marie Saint-Hilaire, Diego Torres-Russotto, Raymond Sanchez, Matthew Leoni, Sridhar Duvvuri, Cari Combs, Ih Chang, Stacey Tringali, Joey Boiser, Cindy Zadikoff, Angelo Antonini
May 1, 2026

Related Content

Baptist Health South Florida

Baptist Health Foundation Receives $2M Gift to Establish Endowed Chair at Baptist Health Miami Neuroscience Institute

Baptist Health Foundation announced that it has received a $2 million donation from Anthony and Joyce Esernia to establish a new endowed chair at Baptist Health Miami Neuroscience Institute.

by
May 1, 2026
5 min

Frontiers In Endocrinology

The novel GLP-1/GIP dual receptor agonist DA5-CH is superior to tirzepatide and exendin-4 in the 6-OHDA Parkinson rat model

Frontiers In Psychiatry

Lorazepam-induced full resolution of catatonia and psychosis in Parkinson’s disease with acromegaly: a case report